66
Participants
Start Date
August 30, 2022
Primary Completion Date
January 31, 2025
Study Completion Date
January 31, 2025
National Institutes of Health Clinical Center, Bethesda
INOVA Fairfax Medical Campus, Fairfax
National Cancer Institute (NCI)
NIH